Emphysema

Source: Wikipedia, the free encyclopedia.
(Redirected from
Bullous emphysema
)
Emphysema
lung volume reduction[4]
MedicationInhaled bronchodilators and corticosteroids[4]

Emphysema is any air-filled enlargement in the body's tissues.

alveoli) in the lungs,[5]
and is also known as pulmonary emphysema.

Emphysema is a

walls of the alveoli, which replace the spongy lung tissue. This reduces the total alveolar surface available for gas exchange leading to a reduction in oxygen supply for the blood.[7] Emphysema usually affects the middle aged or older population because it takes time to develop with the effects of tobacco smoking, and other risk factors. Alpha-1 antitrypsin deficiency is a genetic risk factor that may lead to the condition presenting earlier.[8]

When associated with significant airflow limitation, emphysema is a

spontaneous pneumothorax.[14][15]

There are four types of emphysema, three of which are related to the anatomy of the

Ritalin lung. Only the first two types of emphysema – centrilobular and panlobular – are associated with significant airflow obstruction, with that of centrilobular emphysema around 20 times more common than panlobular. Centrilobular emphysema is the only type associated with smoking.[16]

corticosteroids for treating exacerbations is a significant risk factor for osteoporosis, and their repeated use is recommended against.[18]

Signs and symptoms

Diagram of alveoli with emphysema

Emphysema is a respiratory disease of the

lower respiratory tract.[6] It is commonly caused by tobacco smoking but a significant number of people are affected who either do not smoke, or have never smoked.[13] The presence of emphysema is a clear risk factor for the development of lung cancer, made stronger in those who smoke.[19]

Early symptoms of emphysema may vary from person to person. Symptoms can include a cough (with or without sputum), wheezing, a fast breathing rate, breathlessness on exertion, and a feeling of tightness in the chest. There may be frequent cold or flu infections.[1] Other symptoms may include anxiety, depression, fatigue, sleep problems and weight loss. These symptoms could also relate to other lung conditions or other health problems;[20] therefore, emphysema is often underdiagnosed.[citation needed] The shortness of breath caused by emphysema can increase over time and develop into chronic obstructive pulmonary disease.

A sign of emphysema in smokers is the finding of a higher number of alveolar macrophages sampled from the bronchoalveolar lavage (BAL) in the lungs. The number can be four to six times greater in those who smoke than in non-smokers.[21]

Emphysema is also associated with barrel chest.

Types

There are four main types of emphysema, three of which are related to the anatomy of the

lobules of the lung – centrilobular or centriacinar, panlobular or panacinar, and paraseptal or distal acinar and are not associated with fibrosis (scarring).[16] Although fibrosis is not a normal feature of these subtypes, repair strategies in end-stage emphysema may lead to pulmonary fibrosis.[13] The fourth subtype is known as paracicatricial emphysema or irregular emphysema, involves the acinus irregularly and is associated with fibrosis.[16]

Only the first two types of emphysema – centrilobular and panlobular – are associated with significant airflow obstruction, with that of centrilobular emphysema around 20 times more common than panlobular.[16] The subtypes can be seen on imaging but are not well-defined clinically.[17] There are also a number of associated conditions including bullous emphysema, focal emphysema, and Ritalin lung.

Centrilobular

Stained lung tissue from end-stage emphysema

Centrilobular emphysema, also called centriacinar emphysema, affects the centre of a

pulmonary lobule (centrilobular) in the lung, the area around the terminal bronchiole and the first respiratory bronchiole, and can be seen on imaging as an area around the tip of the visible pulmonary artery. Centrilobular emphysema is the most common type usually associated with smoking, and with chronic bronchitis.[16] The disease progresses from the centrilobular portion, leaving the lung parenchyma in the surrounding (perilobular) region preserved.[22] Usually the upper lobes of the lungs are affected.[16]

Panlobular

Panlobular emphysema, also called panacinar emphysema, affects all of the alveoli in a lobule, and can involve the whole lung or mainly the lower lobes.

Ritalin lung,[23] and is not related to smoking.[17]

Complications

Likely complications of centrilobular and panlobular emphysema, some of which are life-threatening, include: respiratory failure, pneumonia, respiratory infections, pneumothorax, interstitial emphysema, pulmonary heart disease, and respiratory acidosis.[24]

Paraseptal

Paraseptal emphysema, also called distal acinar emphysema, relates to emphysematous change next to a

pleural surface, or to a fissure.[17][25] The cystic spaces known as blebs or bullae that form in paraseptal emphysema typically occur in just one layer beneath the pleura. This distinguishes it from the honeycombing of small cystic spaces seen in fibrosis that typically occurs in layers.[25] This type of emphysema is not associated with airflow obstruction.[26]

Bullous

bullous emphysema

When the subpleural bullae are significant, the emphysema is called bullous emphysema. Bullae can become extensive and combine to form giant bullae. These can be large enough to take up a third of a hemithorax, compress the lung parenchyma, and cause displacement. The emphysema is now termed giant bullous emphysema, more commonly called vanishing lung syndrome due to the compressed parenchyma.[27] A bleb or bulla may sometimes rupture and cause a pneumothorax.[16]

Paracicatricial

Paracicatricial emphysema, also known as irregular emphysema, is seen next to areas of

pulmonary infarction. It can be difficult to differentiate from the honeycombing of pulmonary fibrosis.[28]

HIV associated

Classic lung diseases are a complication of HIV/AIDS with emphysema being a source of disease. HIV is cited as a risk factor for the development of emphysema and COPD regardless of smoking status.[29] Around 20 percent of those with HIV have increased emphysematous changes. This has suggested that an underlying mechanism related to HIV is a contributory factor in the development of emphysema. HIV associated emphysema occurs over a much shorter time than that associated with smoking; an earlier presentation is also seen in emphysema caused by alpha-1 antitrypsin deficiency. Both of these conditions predominantly show damage in the lower lungs, which suggests a similarity between the two mechanisms.[30]

Alpha-1 related

Emphysema may develop in some people with alpha-1 antitrypsin deficiency, the only genotype of chronic obstructive pulmonary disease. This usually occurs a lot earlier (as does HIV associated emphysema) than other types.[31]

Ritalin lung

The intravenous use of

stimulant drug in the treatment of attention deficit hyperactivity disorder, can lead to emphysematous changes known as Ritalin lung. The mechanism underlying this link is not clearly understood. Ritalin tablets are not intended to be injected. They contain talc as a filler, and must be crushed and dissolved to make injection possible. It has been suggested that the talc exposure causes granulomatosis leading to alveolar destruction. However, other intravenous drugs also contain talc, and no emphysematous change is associated with those. High resolution CT scanning shows the emphysema to be panlobular.[32]

CPFE

Combined pulmonary fibrosis and emphysema (CPFE) is a rare syndrome that shows upper-lobe emphysema, together with lower-lobe interstitial fibrosis. This is diagnosed by CT scan.[33] This syndrome presents a marked susceptibility for the development of pulmonary hypertension.[34]

SRIF

Smoking-related interstitial fibrosis (SRIF) is another type of fibrosis that occurs in emphysematous lungs and can be identified by pathologists. Unlike CPFE, this type of fibrosis is usually clinically occult (i.e., does not cause symptoms or imaging abnormalities). Occasionally, however, some patients with SRIF present with symptoms and radiologic findings of interstitial lung disease.[35]

Congenital lobar

Congenital lobar emphysema (CLE), also known as congenital lobar overinflation and infantile lobar emphysema,

lung lobes more than the lower lobes, and the left lung more often than the right lung.[37] CLE is defined as the hyperinflation of one or more lobes of the lung due to the partial obstruction of the bronchus. This causes symptoms of pressure on the nearby organs. It is associated with several cardiac abnormalities such as patent ductus arteriosus, atrial septal defect, ventricular septal defect, and tetralogy of Fallot.[38] Although CLE may be caused by the abnormal development of bronchi, or compression of airways by nearby tissues, no cause is identified in half of cases.[37] CT scan of the lungs is useful in assessing the anatomy of the lung lobes and status of the neighbouring lobes on whether they are hypoplastic or not. Contrast-enhanced CT is useful in assessing vascular abnormalities and mediastinal masses.[38]

Focal

A large bulla and a smaller bleb illustrated

Focal emphysema is a localized region of emphysema in the lung that is larger than alveoli, and often associated with

lung cyst by their size and wall thickness. A bleb or bulla has a wall thickness of less than 1 mm, and are smaller.[41]

Occupational

A number of occupations are associated with the development of emphysema due to the inhalation of varied gases and particles. In the US

radon gas and particles has been shown to be a cause of emphysema deaths; the figures in the study included some miners who also smoked. Uranium mining and milling was found to create environmental pollution.[42]

The inhalation of

coal macule, and this extends into progressive centrilobular emphysema. Less commonly a variant of panlobular emphysema develops.[43]

silica particles, and the formation of large silica nodules is associated with paracicatricial emphysema, with or without bullae.[44]

Ozone-induced emphysema

Ozone is another pollutant that can affect the respiratory system. Long-term exposure to ozone can result in emphysema.[45]

Osteoporosis

corticosteroids for treating exacerbations is a significant risk factor for osteoporosis, and their repeated use is not recommended.[18]

Other terms

Further information: Pneumatosis

Compensatory emphysema is overinflation of part of a lung in response to either removal by surgery of another part of the lung or decreased size of another part of the lung.[47]

Pulmonary interstitial emphysema (PIE) is a collection of air inside the lungs but outside the normal air space of the alveoli, found as pneumatoses inside the connective tissue of the peribronchovascular sheaths, interlobular septa, and visceral pleura.

Lung volume reduction

Lung volume reduction may be offered to those with advanced emphysema. When other treatments fail, and the emphysema is located in the upper lobes, a surgical option may be possible.

bronchoscopic procedures are increasingly used to reduce lung volume.[49]

Surgical

Where there is severe emphysema with significant hyperinflation that has proved unresponsive to other therapies,

lung volume reduction surgery (LVRS) may be an option.[50][51] LVRS involves the removal of tissue from the lobe most damaged by emphysema, which allows the other lobes to expand and give improved function. The procedure appears to be particularly effective if the emphysema primarily involves the upper lobes; however, the procedure increases the risk of adverse events and early death in people who have diffuse emphysema.[52][48]

Bronchoscopic

Further information: Bronchoscopic lung volume reduction

Minimally invasive bronchoscopic procedures may be carried out to reduce lung volume. These include the use of valves, coils, or thermal ablation.[53][54] Endobronchial valves are one-way valves that may be used in those with severe hyperinflation resulting from advanced emphysema; a suitable target lobe and no collateral ventilation are required for this procedure. The placement of one or more valves in the lobe induces a partial collapse of the lobe that ensures a reduction in residual volume that improves lung function, the capacity for exercise, and quality of life.[55]

The placement of endobronchial coils made of

nitinol, instead of valves is recommended where there is collateral ventilation that would prevent the use of valves.[56][57] Nitinol is a biocompatible shape-memory alloy
.

Both of these techniques are associated with adverse effects, including persistent air leaks and cardiovascular complications. Bronchoscopic thermal vapor ablation has an improved profile. Heated water vapor is used to target affected lobe regions, which leads to permanent fibrosis and volume reduction. The procedure is able to target individual lobe segments, can be carried out regardless of collateral ventilation, and can be repeated with the natural advance of emphysema.[58]

Other surgeries

Lung transplantation – the replacement of either a single lung or both (bilateral) – may be considered in end-stage disease. A bilateral transplant is the preferred choice as complications can arise in a remaining single native lung; complications can include hyperinflation, pneumonia, and the development of lung cancer.[59] Careful selection as recommended by the National Emphysema Treatment Trial (NETT) for transplant surgeries is needed as in some cases there will be an increased risk of mortality.[48] Several factors including age, and poor exercise tolerance, using the BODE index need to be taken into account.[59] A transplant is only considered where there are no serious comorbidites.[49] A CT scan or a ventilation/perfusion scan may be useful in surgery considerations to evaluate cases for surgical interventions, and also to evaluate post-surgery responses.[60] A bullectomy may be carried out when a giant bulla occupies more than a third of a hemithorax.[49]

In other tissues

Trapped air can also develop in other tissues such as under the skin, known as

palpebral emphysema that affects just the eyelids.[61] Emphysematous gastritis is the presence of air in the stomach wall, usually caused by a bacterial infection. This is a rare occurrence but has a high mortality rate.[62]

History

Giovanni Battista Morgagni, who recorded one of the earliest descriptions of emphysema in 1769

The terms emphysema and chronic bronchitis were formally defined in 1959 at the CIBA guest symposium, and in 1962 at the American Thoracic Society Committee meeting on Diagnostic Standards.[63] The word emphysema is derived from Ancient Greek ἐμφύσημα 'inflation, swelling'[64] (referring to a lung inflated by air-filled spaces), itself from ἐμφυσάω emphysao 'to blow in, to inflate',[65] composed of ἐν en, meaning "in", and φυσᾶ physa,[66] meaning "wind, blast".[67][68]

Giovanni Morgagni of lungs which were "turgid particularly from air".[63][69] In 1721 the first drawings of emphysema were made by Ruysh.[69] These were followed the illustrations of Matthew Baillie
in 1789 and descriptions of the destructive nature of the condition.

References

  1. ^ a b c d e "Emphysema". medlineplus.gov. Retrieved 7 February 2024.
  2. ^ Gold Report 2021, pp. 20–23, Chapter 2: Diagnosis and initial assessment.
  3. ^ Gold Report 2021, pp. 33–35, Chapter 2: Diagnosis and initial assessment.
  4. ^ a b c Gold Report 2021, pp. 40–46, Chapter 3: Evidence supporting prevention and maintenance therapy.
  5. ^ a b "Definition of Emphysema". Merriam-Webster. Retrieved 10 April 2023.
  6. ^ a b "ICD-11 – ICD-11 for Mortality and Morbidity Statistics". icd.who.int. Retrieved 9 August 2021.
  7. ISBN 9780071222075
    .
  8. ^ Murphy A, Danaher L. "Pulmonary emphysema". radiopaedia.org. Retrieved 16 August 2019.
  9. ^ Algusti AG, et al. (2017). "Definition and Overview". Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD). pp. 6–17.
  10. doi:10.1186/s40749-017-0024-y
    .
  11. ^ Diedtra Henderson (2014-12-16). "Emphysema on CT Without COPD Predicts Higher Mortality Risk". Medscape.
  12. ^ "FastStats – Chronic Lower Respiratory Disease". www.cdc.gov. 23 May 2019. Retrieved 30 May 2019.
  13. ^
    PMID 33313212
    .
  14. S2CID 59233744
    .
  15. ^ Coffey D (15 November 2022). "Buzz Kill: Lung Damage Looks Worse in Pot Smokers". Medscape.
  16. ^ a b c d e f g h i Kumar 2018, pp. 498–501.
  17. ^
    PMID 24384106
    .
  18. ^ a b "COPD and comorbidities" (PDF). p. 133. Retrieved 24 September 2019.
  19. ^ Global Strategy for Prevention, Diagnosis and Management of COPD: 2021 Report (PDF). 25 November 2020. p. 123. Retrieved 3 October 2021.
  20. ^ "Pulmonary Emphysema". www.hopkinsmedicine.org. 19 November 2019. Retrieved 3 October 2021.
  21. PMID 30020685
    . Retrieved 22 October 2021.
  22. PMID 18686729
    .
  23. ^
    S2CID 239605521
    . Retrieved 22 May 2019.
  24. PMID 29489292
    . Retrieved 26 August 2021.
  25. ^ a b "Chest". Radiology assistant. Retrieved 20 June 2019.
  26. ^ Mosenifar Z (April 2019). "Chronic Obstructive Pulmonary Disease (COPD)". emedicine.medscape. Retrieved 25 July 2019.
  27. S2CID 882767
    .
  28. ^ Weerakkody Y. "Paracicatricial emphysema | Radiology Reference Article | Radiopaedia.org". Radiopaedia. Retrieved 28 July 2021.
  29. PMID 34285903
    .
  30. PMID 29351445
    .
  31. ^ "Alpha-1 antitrypsin deficiency: MedlinePlus Genetics". medlineplus.gov. Retrieved 26 August 2021.
  32. ^ Sharma R. "Ritalin lung". radiopaedia.org. Retrieved 9 July 2019.
  33. PMID 29374870
    .
  34. PMID 24355635
    .
  35. PMID 36495281
    .
  36. ^ "UpToDate: Congenital lobar emphysema". Retrieved 10 July 2016.
  37. ^
    PMID 22595712
    .
  38. ^
    PMID 31118601
    .
  39. ISBN 9780323523714
    .
  40. ^ Weerakkody Y. "Localised pulmonary emphysema | Radiology Reference Article | Radiopaedia.org". Radiopaedia. Retrieved 2 August 2021.
  41. ^ Gaillard F. "Pulmonary bullae | Radiology Reference Article | Radiopaedia.org". Radiopaedia. Retrieved 16 June 2019.
  42. ^ "Worker Health Study Summaries – Uranium Miners | NIOSH | CDC". www.cdc.gov. 15 June 2020. Retrieved 29 July 2021.
  43. ^ "Pathology Basis of Occupational Lung Disease, Pneumoconiosis | NIOSH | CDC". www.cdc.gov. 5 August 2020. Retrieved 31 July 2021.
  44. ^ "Pathology Basis of Occupational Lung Disease, Silicosis | NIOSH | CDC". www.cdc.gov. 5 August 2020. Retrieved 31 July 2021.
  45. PMID 31354743
    .
  46. PMID 22793940
    .
  47. ISBN 9789811316197
    .
  48. ^
    S2CID 12014757
    .
  49. ^
    S2CID 221145423
    .
  50. ^ Gold Report 2021, p. 96, Chapter 4: Management of stable COPD.
  51. S2CID 73428098
    .
  52. PMID 27739074
    .
  53. ^ Gold Report 2021, pp. 60–65, Chapter 3: Evidence supporting prevention and maintenance therapy.
  54. ^ "1 Recommendations | Endobronchial valve insertion to reduce lung volume in emphysema | Guidance | NICE". www.nice.org.uk. 20 December 2017. Retrieved 7 July 2021.
  55. PMID 33345947
    .
  56. PMID 29991060
    .
  57. PMID 30210833
    .
  58. S2CID 78181696
    . Retrieved 3 July 2021.
  59. ^
    PMID 33313218
    .
  60. S2CID 56486118
    .
  61. PMID 8309261
    . Retrieved 10 April 2023.
  62. PMID 31334970
    . Retrieved 5 December 2023.
  63. ^
    PMID 18046898
    .
  64. ^ "Greek Word Study Tool – ἐμφύσημα". www.perseus.tufts.edu. Retrieved 2021-08-25.
  65. ^ "Greek Word Study Tool". www.perseus.tufts.edu. Retrieved 2021-08-25.
  66. ^ "Greek Word Study Tool". www.perseus.tufts.edu. Retrieved 2021-08-25.
  67. ^ & Klein 1971, p. 245.
  68. ^ "Emphysema". Dictionary.com. Archived from the original on 24 November 2013. Retrieved 21 November 2013.
  69. ^ a b Wright & Churg 2008, pp. 693–705.

Bibliography

External links

Retrieved from "https://en.wikipedia.org/w/index.php?title=Emphysema&oldid=1219004381#Bullous"